Flow Pharma has created FlowVax HPV, an immunotherapy designed to work synergistically with existing treatment options to address HPV-induced cervical and throat cancer.
HPV (human papillomavirus) causes virtually all cervical cancers, as well as most oral-pharyngeal cancers.